Medical Developments International (ASX:MVP) Change In Inventory: A$0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:MVP Medical Developments International Ltd ASX:MVP
51 GF Score
Price A$0.41
GF Value A$0.65
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Medical Developments International Change In Inventory?

Medical Developments International ASX:MVP 51 Change In Inventory is A$0.00 Mil as of Dec. 2025. GuruFocus rates ASX:MVP with a GF Score™ of 51/100 and a GF Value™ of A$0.65 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Medical Developments International's change in inventory for the quarter that ended in Dec. 2025 was A$0.00 Mil. It means Medical Developments International's inventory stayed the same from Jun. 2025 to Dec. 2025 .

Medical Developments International's change in inventory for the fiscal year that ended in Jun. 2025 was A$0.00 Mil. It means Medical Developments International's inventory stayed the same from Jun. 2024 to Jun. 2025 .

Medical Developments International's Total Inventories for the quarter that ended in Dec. 2025 was A$8.50 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Medical Developments International's Days Inventory for the quarter that ended in Dec. 2025 was 286.12.

Inventory Turnover measures how fast the company turns over its inventory within a year. Medical Developments International's Inventory Turnover for the quarter that ended in Dec. 2025 was 0.64.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Medical Developments International's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.42.


Medical Developments International  (ASX:MVP) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Medical Developments International's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=8.9725/5.723*365 / 2
=286.12

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Medical Developments International's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Medical Developments International's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medical Developments International Change In Inventory Related Terms


Medical Developments International Change In Inventory Historical Data

* Premium members only.

The historical data trend for Medical Developments International's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Developments International Change In Inventory Chart

Medical Developments International Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Medical Developments International Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:MVP
51GF Score
Medical Developments International Ltd ASX:MVP
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medical Developments International Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of A$0.00 Mil mean?
Medical Developments International (ASX:MVP) has a Change In Inventory of A$0.00 Mil as of Dec. 2025. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Medical Developments International and its competitors.
Is Medical Developments International's Change In Inventory too high?
Medical Developments International's current Change In Inventory is A$0.00 Mil. Overall, Medical Developments International has a GF Score™ of 51/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Developments International's Change In Inventory compare to ZTS and UTHR?
Medical Developments International's Change In Inventory of A$0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Drug Manufacturers company?
A good Change In Inventory depends on the Drug Manufacturers industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Medical Developments International and its competitors. Medical Developments International's current Change In Inventory is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Developments International stock overvalued right now?
Based on GuruFocus' analysis, Medical Developments International (ASX:MVP) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.65, compared to a current price of A$0.41 — trading 36.9% below its estimated fair value. The current Change In Inventory is A$0.00 Mil. Medical Developments International's overall GF Score™ is 51/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Medical Developments International (ASX:MVP), the current Change In Inventory is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medical Developments International (ASX:MVP) Overvalued in 2026?

Based on GuruFocus' analysis, Medical Developments International stock appears to be undervalued. The current stock price of A$0.41 is trading 36.9% below its estimated GF Value™ of A$0.65. GuruFocus considers Medical Developments International to be Significantly Undervalued.

Key valuation signals for ASX:MVP:

  • Change In Inventory: A$0.00 Mil
  • GF Value™: A$0.65 vs. price of A$0.41 (36.9% below fair value)
  • GF Score™: 51/100 with 2 warning signs

No single metric tells the full story. See the ASX:MVP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medical Developments International Business Description

Other Exchanges MDDVF:USAM5D:Germany
Address 4 Caribbean Drive, Scoresby, VIC, AUS, 3179
Medical Developments International Ltd is a specialized healthcare company. The Company manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product, used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The segments of the company are Pain Management and Respiratory. The company derives maximum revenue from the Pain management segment.
51GF Score

Get the complete analysis for ASX:MVP

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.41
Price
A$0.65
GF Value